kabutan

PhoenixBio, Last Fiscal Year Ordinary Profit Loss to Narrow

Wed Apr 30, 2025 4:00 pm JST Revision

6190 PhoenixBio Co.,Ltd. 【J-GAAP】

Guidance Update Report

PhoenixBio Co.,Ltd. <6190> [TSE Growth] announced a performance revision after the market closed on April 30th (16:00). The consolidated ordinary profit/loss for the fiscal year ending March 2025 has been revised upward from an expected loss of 277 million yen to a loss of 151 million yen (compared to a profit of 43 million yen in the previous period), indicating a reduction in the loss margin. However, the full-year consolidated net income/loss has been revised downward from an expected loss of 281 million yen to a loss of 445 million yen (compared to a profit of 26 million yen in the previous period), indicating an expansion in the loss margin.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit/loss has been revised upward from an expected loss of 154 million yen to a loss of 28 million yen (compared to a loss of 2 million yen in the same period of the previous year), indicating a reduction in the loss margin.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 Prev 733 -155 -154 -157 -38.8 0 Nov 14, 2024 J-GAAP
Oct - Mar, 2024 New 753 -44 -28 -321 -79.4 0 Apr 30, 2025 J-GAAP
Revision Rate +2.7% +71.6% +81.8% -104.5% -104.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 1,521 -253 -277 -281 -69.4 0 Nov 14, 2024 J-GAAP
Mar, 2025 New 1,541 -142 -151 -445 -110.1 0 Apr 30, 2025 J-GAAP
Revision Rate +1.3% +43.9% +45.5% -58.4% -58.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 834 16 -2 -1 -0.3 0 May 15, 2024 J-GAAP
Oct - Mar, 2024 Guidance 753 -44 -28 -321 -79.4 0 Apr 30, 2025 J-GAAP
YoY -9.7% － -1,300.0% -32,000.0% -29,307.4%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 2,124 508 511 493 145.2 0 May 15, 2023 J-GAAP
Mar, 2024 1,715 11 43 26 7.0 0 May 15, 2024 J-GAAP
Mar, 2025 Guidance 1,541 -142 -151 -445 -110.1 0 Apr 30, 2025 J-GAAP
YoY -10.1% － － － －

Related Articles